Streetbeat News

Regulatory

TCNNF

Florida state senators from both parties are supporting the cannabis legalization initiative, Amendment 3, which will be on the November 2024 ballot. The initiative could generate significant tax revenue and is backed by Trulieve Cannabis Corp, despite opposition from Governor Ron DeSantis.

Portfolio Pulse from Maureen Meehan

September 11, 2024 | 9:02 pm

SGMA

SigmaTron International has regained compliance with Nasdaq's listing requirements, which is a positive development for the company and its investors.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 8:33 pm

WNW

Meiwu Technology has received a notification letter from Nasdaq, which could have implications for its listing status. This development is crucial for investors to monitor as it may affect the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 8:16 pm

VSEE

VSee Health has received a notice from Nasdaq for non-compliance due to a delay in filing its Q2 2024 10-Q report. This could impact its stock listing status.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 8:16 pm

BLEU

Bleuacacia has received a deficiency notice from Nasdaq, indicating potential issues with its compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 8:01 pm

BA

The FAA Administrator has indicated that Boeing is on a 'very long term journey' to implement necessary safety improvements. This suggests ongoing challenges for Boeing in meeting regulatory safety standards.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 7:14 pm

NVDA

NVIDIA shares are rising due to a report that the U.S. Government might permit the export of its AI chips to Saudi Arabia. Additionally, Vice President Harris expressed a desire to invest in American technology to lead in AI and quantum computing.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 7:10 pm

UAL

The Federal Aviation Administration (FAA) is nearing completion of a safety audit of United Airlines. This audit is part of routine checks to ensure compliance with safety regulations.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 7:03 pm

ABBV

AMGN

CI

CVS

PFE

UNH

UnitedHealth Group will remove AbbVie's Humira from its preferred reimbursement lists in 2025, opting for lower-cost biosimilars. This follows similar moves by Cigna and CVS Health. Despite competition, AbbVie retains a dominant market share for Humira.

Portfolio Pulse from Vandana Singh

September 11, 2024 | 6:59 pm